Olanzapine versus Risperidone in the Treatment of Schizophrenia
- 1 January 2003
- journal article
- research article
- Published by Springer Nature in PharmacoEconomics
- Vol. 21 (10) , 683-697
- https://doi.org/10.2165/00019053-200321100-00001
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Use and Costs of Ambulatory Care Services Among Medicare Enrollees With SchizophreniaPsychiatric Services, 2001
- Comparison of Discharge Rates and Drug Costs for Patients With Schizophrenia Treated With Risperidone or OlanzapinePsychiatric Services, 2001
- OlanzapineDrugs, 2001
- Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patientsSchizophrenia Research, 1999
- OlanzapinePharmacoEconomics, 1999
- ECONOMETRICS IN OUTCOMES RESEARCH: The Use of Instrumental VariablesAnnual Review of Public Health, 1998
- Cost Analysis of the Treatment of Schizophrenia in the UKPharmacoEconomics, 1998
- Prior hospitalization and age as predictors of mental health resource utilization in IsraelSocial Science & Medicine, 1997
- Economic outcomes and costs in the treatment of schizophreniaClinical Therapeutics, 1997
- Generalized Econometric Models with SelectivityEconometrica, 1983